» Articles » PMID: 9848786

Human Complement Factor H Deficiency Associated with Hemolytic Uremic Syndrome

Overview
Specialty Nephrology
Date 1998 Dec 16
PMID 9848786
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

This study reports on six cases of deficiency in the human complement regulatory protein Factor H (FH) in the context of an acute renal disease. Five of the cases were observed in children presenting with idiopathic hemolytic uremic syndrome (HUS). Two of the children exhibited a homozygous deficiency characterized by the absence of the 150-kD form of Factor H and the presence, upon immunoblotting, of the 42-kD Factor H-like protein 1 (FHL-1) and other FH-related protein (FHR) bands. Southern blot and PCR analysis of DNA of one patient with homozygous deficiency ruled out the presence of a large deletion of the FH gene as the underlying defect for the deficiency. The other four children presented with heterozygous deficiency and exhibited a normal immunoblotting pattern of proteins of the FH family. Factor H deficiency is the only complement deficiency associated with HUS. These observations suggest a role for FH and/or FH receptors in the pathogenesis of idiopathic HUS.

Citing Articles

The human factor H protein family - an update.

Sandor N, Schneider A, Matola A, Barbai V, Bencze D, Hammad H Front Immunol. 2024; 15:1135490.

PMID: 38410512 PMC: 10894998. DOI: 10.3389/fimmu.2024.1135490.


Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis.

Li L, Luan Z, Tan Y, Wang H, Yu X, Qu Z Immunol Res. 2023; 71(6):849-859.

PMID: 37322353 PMC: 10667379. DOI: 10.1007/s12026-023-09396-y.


Genome-wide identification of antisense lncRNAs and their association with susceptibility to in rainbow trout.

Ali A, Salem M Front Immunol. 2022; 13:1050722.

PMID: 36561762 PMC: 9763276. DOI: 10.3389/fimmu.2022.1050722.


Kidney diseases.

Daina E, Cortinovis M, Remuzzi G Immunol Rev. 2022; 313(1):239-261.

PMID: 36369988 PMC: 10099622. DOI: 10.1111/imr.13167.


Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.

Bansal L, Nichols E, Howsmon D, Neisen J, Bessant C, Cunningham F Front Pharmacol. 2022; 13:855743.

PMID: 35517827 PMC: 9061988. DOI: 10.3389/fphar.2022.855743.